Intraoperative 3D Imaging System Advances Robotic Navigation Backbone Surgical procedure
AUDUBON, Pa., Could 18, 2022 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a number one musculoskeletal options firm, introduced in the present day the primary surgical procedures carried out with the Excelsius3D™, an clever, intraoperative 3-in-1 imaging platform, the newest addition to Globus Medical’s Excelsius™ Ecosystem.
Paul C. McAfee, MD, MBA and Mesfin A. Lemma, MD at MedStar Union Memorial Hospital, Roland Kent, MD at Northwest Specialty Hospital, and Jeffrey A. Goldstein, MD at NYU Langone Health, every carried out the primary medical instances utilizing Excelsius3D™ with ExcelsiusGPS®.
Dr. Lemma, Division Chief of Backbone Surgical procedure and Director of Minimally Invasive Backbone Surgical procedure at MedStar Union Memorial Hospital believes “the Excelsius™ Ecosystem can assist us present sufferers with minimally invasive therapy choices. We’re excited in regards to the addition of the brand new Excelsius3D™ imaging system to our ExcelsiusGPS® robotic navigation platform at MedStar Union Memorial Hospital.”
“With these two applied sciences, we’re in a position to effectively carry out surgical procedure with minimally invasive strategies. The seamless interface between the 2 platforms permits us to supply the perfect modern expertise to sufferers,” added Dr. McAfee, Orthopedic Backbone Surgeon at MedStar Union Memorial Hospital.
Dr. Kent, founding father of Axis Backbone and surgeon at Northwest Specialty Hospital, added, “we’re very proud to function a number of the most superior surgical backbone options within the nation. We’ve carried out over 700 instances with ExcelsiusGPS® and are actually excited so as to add Excelsius3D™ to supply our sufferers with extra environment friendly surgical options which have the potential to additional enhance surgical outcomes.”
Dr. Goldstein, Director of Training, Division of Backbone Surgical procedure and Director of the Backbone Surgical procedure Fellowship at NYU Langone Health, acknowledged, “the addition of Excelsius3D™ to our working room has helped to streamline our navigation workflow with ExcelsiusGPS®. The intraoperative imaging expertise permits us to effectively visualize anatomy, gives three imaging modes in a single complete system, and is simple for our radiology technicians to maneuver and place. We’re enthusiastic about this new software to assist us present sufferers with the very best care.”
Excelsius3D™ is the newest addition to Globus Medical’s progressive platform of enabling applied sciences. Excelsius3D™ mixed with the ExcelsiusGPS® robotic navigation system gives a superior intraoperative, image-guided robotic navigation answer, and is designed to enhance implant placement accuracy, decrease radiation publicity, and shorten operative occasions. Excelsius3D™ is now commercially out there in america.
Indications for Use
Excelsius3D™ is a cell X-ray system designed for 2D fluoroscopy, 2D digital radiography, and 3D imaging of grownup and pediatric sufferers. The system is indicated to be used the place a doctor advantages from 2D and 3D info on anatomic buildings and excessive distinction objects with excessive x-ray attenuation similar to bony anatomy and metallic objects. Excelsius3D™ photos are suitable with picture guided techniques similar to ExcelsiusGPS®.
About Globus Medical, Inc.
Globus Medical, Inc. is a number one musculoskeletal options firm primarily based in Audubon, PA. The corporate was based in 2003 by an skilled workforce of execs with a shared imaginative and prescient to create merchandise that allow surgeons to advertise therapeutic in sufferers with musculoskeletal issues. Further info could be accessed at http://www.globusmedical.com.
Secure Harbor Statements
All statements included on this press launch aside from statements of historic truth are forward-looking statements and could also be recognized by their use of phrases similar to “consider,” “could,” “may,” “may,” “will,” “goal,” “estimate,” “proceed,” “anticipate,” “intend,” “count on,” “plan” and different related phrases. These forward-looking statements are primarily based on our present assumptions, expectations and estimates of future occasions and traits. Ahead-looking statements are solely predictions and are topic to many dangers, uncertainties and different components which will have an effect on our companies and operations and will trigger precise outcomes to vary materially from these predicted. These dangers and uncertainties embrace, however aren’t restricted to, well being epidemics, pandemics and related outbreaks, together with the COVID-19 pandemic, components affecting our quarterly outcomes, our capacity to handle our progress, our capacity to maintain our profitability, demand for our merchandise, our capacity to compete efficiently (together with with out limitation our capacity to persuade surgeons to make use of our merchandise and our capacity to draw and retain gross sales and different personnel), our capacity to quickly develop and introduce new merchandise, our capacity to develop and execute on profitable enterprise methods, our capacity to adjust to legal guidelines and rules which can be or could change into relevant to our companies, our capacity to safeguard our mental property, our success in defending authorized proceedings introduced towards us, traits within the medical machine business, common financial situations, and different dangers. For a dialogue of those and different dangers, uncertainties and different components that would have an effect on our outcomes, it is best to seek advice from the disclosure contained in our most up-to-date annual report on Type 10-Okay filed with the Securities and Trade Fee, together with the sections labeled “Danger Components” and “Cautionary Notice Regarding Ahead-Wanting Statements,” and in our Types 10-Q, Types 8-Okay and different filings with the Securities and Trade Fee. These paperwork can be found at www.sec.gov. Furthermore, we function in an evolving surroundings. New danger components and uncertainties emerge sometimes and it isn’t doable for us to foretell all danger components and uncertainties, nor can we assess the affect of all components on our enterprise or the extent to which any issue, or mixture of things, could trigger precise outcomes to vary materially from these contained in any forward-looking statements. Given these dangers and uncertainties, readers are cautioned to not place undue reliance on any forward-looking statements. Ahead-looking statements contained on this press launch converse solely as of the date of this press launch. We undertake no obligation to replace any forward-looking statements because of new info, occasions or circumstances or different components arising or coming to our consideration after the date hereof.
Contact:
Brian Kearns
Senior Vice President, Enterprise Growth and Investor Relations
Cellphone: (610) 930-1800
E mail: traders@globusmedical.com
www.globusmedical.com
Discussion about this post